Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Ueda

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|January 22, 2005
Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131Hirokazu Tamamura, Kenichi Hiramatsu, Satoshi Ueda, et al.
Journal of Medicinal Chemistry|April 29, 2005
Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffoldsHirokazu Tamamura, Takanobu Araki, Satoshi Ueda, et al.
Journal of Medicinal Chemistry|January 19, 2007
Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalitiesSatoshi Ueda, Shinya Oishi, Zi-xuan Wang, et al.
Journal of Pediatric Hematology/Oncology|January 25, 2019
An 18-Year-Old Male With X-linked Lymphoproliferative Syndrome Type 1 Who Developed Primary Central Nervous System Lymphoma 6 Months After Primary Epstein-Barr Virus InfectionNobuyoshi Kusano, Naoki Sakata, Keisuke Sugimoto, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2008
Identification of novel non-peptide CXCR4 antagonists by ligand-based design approachSatoshi Ueda, Manabu Kato, Shinsuke Inuki, et al.
Chembiochem : a European Journal of Chemical Biology|April 17, 2008
Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4Shinya Oishi, Ryo Masuda, Barry Evans, et al.
Organic & Biomolecular Chemistry|December 6, 2005
Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffoldsHirokazu Tamamura, Ai Esaka, Teppei Ogawa, et al.
Transplantation Direct|December 12, 2018
Unilateral Chronic Lung Allograft Dysfunction Assessed by Biphasic Computed Tomographic Volumetry in Bilateral Living-donor Lobar Lung TransplantationMasao Saito, Toyofumi F Chen-Yoshikawa, Yuji Nakamoto, et al.
Organic & Biomolecular Chemistry|December 3, 2003
Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonistsHirokazu Tamamura, Kenichi Hiramatsu, Makiko Mizumoto, et al.
Biochimica Et Biophysica Acta. Bioenergetics|March 27, 2019
Insights into the ubiquinol/dioxygen binding and proton relay pathways of the alternative oxidaseTomoo Shiba, Daniel Ken Inaoka, Gen Takahashi, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|January 22, 2005
Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131Hirokazu Tamamura, Kenichi Hiramatsu, Satoshi Ueda, et al.
Journal of Medicinal Chemistry|April 29, 2005
Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffoldsHirokazu Tamamura, Takanobu Araki, Satoshi Ueda, et al.
Journal of Medicinal Chemistry|January 19, 2007
Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalitiesSatoshi Ueda, Shinya Oishi, Zi-xuan Wang, et al.
Journal of Pediatric Hematology/Oncology|January 25, 2019
An 18-Year-Old Male With X-linked Lymphoproliferative Syndrome Type 1 Who Developed Primary Central Nervous System Lymphoma 6 Months After Primary Epstein-Barr Virus InfectionNobuyoshi Kusano, Naoki Sakata, Keisuke Sugimoto, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2008
Identification of novel non-peptide CXCR4 antagonists by ligand-based design approachSatoshi Ueda, Manabu Kato, Shinsuke Inuki, et al.
Chembiochem : a European Journal of Chemical Biology|April 17, 2008
Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4Shinya Oishi, Ryo Masuda, Barry Evans, et al.
Organic & Biomolecular Chemistry|December 6, 2005
Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffoldsHirokazu Tamamura, Ai Esaka, Teppei Ogawa, et al.
Transplantation Direct|December 12, 2018
Unilateral Chronic Lung Allograft Dysfunction Assessed by Biphasic Computed Tomographic Volumetry in Bilateral Living-donor Lobar Lung TransplantationMasao Saito, Toyofumi F Chen-Yoshikawa, Yuji Nakamoto, et al.
Organic & Biomolecular Chemistry|December 3, 2003
Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonistsHirokazu Tamamura, Kenichi Hiramatsu, Makiko Mizumoto, et al.
Biochimica Et Biophysica Acta. Bioenergetics|March 27, 2019
Insights into the ubiquinol/dioxygen binding and proton relay pathways of the alternative oxidaseTomoo Shiba, Daniel Ken Inaoka, Gen Takahashi, et al.
Pageof 7